Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - European Respiratory …, 2018 - Eur Respiratory Soc
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis.
M Cazzola, P Rogliani, L Calzetta… - The European …, 2018 - europepmc.org
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
[引用][C] Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta, M Matera - EUROPEAN …, 2018 - air.unipr.it
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a
systematic review and meta-analysis IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore …
systematic review and meta-analysis IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore …
[PDF][PDF] Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta, MG Matera - Eur Respir J, 2018 - qdcxjkg.com
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - European Respiratory …, 2018 - cir.nii.ac.jp
抄録< jats: p> We performed a meta-analysis to compare the impact of triple combination
therapy with inhaled corticosteroids (ICS), long-acting β< jats: sub> 2</jats: sub>-agonists …
therapy with inhaled corticosteroids (ICS), long-acting β< jats: sub> 2</jats: sub>-agonists …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - European Respiratory …, 2018 - Eur Respiratory Soc
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β 2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β 2-agonists (LABAs) and long-acting muscarinic …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: A systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - EUROPEAN …, 2018 - iris.unicampania.it
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - The European …, 2018 - pubmed.ncbi.nlm.nih.gov
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β 2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β 2-agonists (LABAs) and long-acting muscarinic …
Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta… - EUROPEAN …, 2018 - art.torvergata.it
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
[PDF][PDF] Triple therapy versus single and dual long-acting bronchodilator therapy in COPD: a systematic review and meta-analysis
M Cazzola, P Rogliani, L Calzetta, MG Matera - Eur Respir J, 2018 - qdcxjkg.com
We performed a meta-analysis to compare the impact of triple combination therapy with
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …
inhaled corticosteroids (ICS), long-acting β2-agonists (LABAs) and long-acting muscarinic …